Will New Black Box Warning About Heart Attacks Lead GlaxoSmithKline To Withdraw Avandia From Market?
November 9th, 2007 Posted by: Dr. Cox
One Wonders Whether GSK Might Do A “Soft” Recall Of Its Embattled Diabetes Drug, As Was Done By BMS With Serzone And Tequin In Recent Years
(Posted by Tom Lamb at DrugInjuryWatch.com)
Avandia (rosiglitazone) is a prescription drug from GlaxoSmithKline (GSK) approved by the FDA in 1999 to treat Type 2 diabetes.